Chromadex Corp (CDXC)

May 15, 2025

ChromaDex (NASDAQ:CDXC) Coverage Initiated by Analysts at StockNews.com - Defense World

May 15, 2025

May 07, 2025

ChromaDex (NASDAQ:CDXC) Now Covered by StockNews.com - Defense World

May 07, 2025

Apr 21, 2025

Supplement Maker Rebrands - Los Angeles Business Journal

Apr 21, 2025

Apr 07, 2025

Niagen Bioscience Confirms Its Operations Remain Unaffected By New Tariffs - MarketScreener

Apr 07, 2025

Apr 07, 2025

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs - Business Wire

Apr 07, 2025

Apr 07, 2025

Niagen Says Its Operations Remain Resilient Amid Recent Tariff Developments - MarketScreener

Apr 07, 2025

Apr 07, 2025

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments - BioSpace

Apr 07, 2025

Apr 07, 2025

Niagen Bioscience maintains stability amid tariffs By Investing.com - Investing.com India

Apr 07, 2025

Apr 07, 2025

Niagen Bioscience maintains stability amid tariffs - Investing.com Australia

Apr 07, 2025

Apr 05, 2025

ChromaDex (NASDAQ:CDXC) Coverage Initiated at StockNews.com - Defense World

Apr 05, 2025

Apr 03, 2025

ChromaDex: Q4 Earnings Snapshot - marketscreener.com

Apr 03, 2025

Apr 02, 2025

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® - MarketScreener

Apr 02, 2025

Mar 31, 2025

H.C. Wainwright holds $11 target on Niagen Bioscience stock By Investing.com - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

H.C. Wainwright holds $11 target on Niagen Bioscience stock - Investing.com

Mar 31, 2025

Mar 25, 2025

Why ChromaDex Corp (CDXC) Is Surging In 2025? - Insider Monkey

Mar 25, 2025

Mar 21, 2025

Botanical Supplements Market In-depth Insights, Business - openPR.com

Mar 21, 2025

Mar 21, 2025

Why These 15 Defensive Stocks Are Surging In 2025 - Insider Monkey

Mar 21, 2025

Mar 21, 2025

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) - Marketscreener.com

Mar 21, 2025

Mar 20, 2025

Niagen Bioscience secures new patent for NAD+ precursors - Investing.com India

Mar 20, 2025

Mar 20, 2025

Niagen Bioscience broadens NAD+ precursor IP portfolio with new patent - TipRanks

Mar 20, 2025

Mar 20, 2025

Niagen Bioscience secures new patent for NAD+ precursors By Investing.com - Investing.com UK

Mar 20, 2025

Mar 20, 2025

Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms - Business Wire

Mar 20, 2025

Mar 19, 2025

ChromaDex Completes Name Change to Niagen Bioscience -March 19, 2025 at 09:29 am EDT - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Chromadex Rebrands to Niagen Bioscience, Inc. - TipRanks

Mar 19, 2025

Mar 19, 2025

ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science - The Bakersfield Californian

Mar 19, 2025

Mar 19, 2025

Chlorinated Isopropane Market Set for 4.9% CAGR Growth, Hitting USD 496.0 Million by 2035 | Fact.MR Report - GlobeNewswire Inc.

Mar 19, 2025

Mar 19, 2025

ChromaDex Corporation will Change its Ticker to NAGE from CDXC - marketscreener.com

Mar 19, 2025

Mar 18, 2025

ChromaDex Corporation will Change its Name to Niagen Bioscience, Inc -March 19, 2025 at 12:00 am EDT - Marketscreener.com

Mar 18, 2025

Mar 18, 2025

ChromaDex’s (CDXC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 18, 2025

Mar 17, 2025

ChromaDex changes name to Niagen Bioscience to home in on healthy aging - SupplySide Supplement Journal

Mar 17, 2025

Mar 17, 2025

Chromadex’s Strategic Rebranding and Promising Clinical Developments Justify Buy Rating - TipRanks

Mar 17, 2025

Mar 17, 2025

ChromaDex rebrands as Niagen Bioscience to reflect growth in supplement, pharmaceutical industries - NutraIngredients-USA.com

Mar 17, 2025

Mar 14, 2025

ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+ - insights.citeline.com

Mar 14, 2025

Mar 14, 2025

ChromaDex to rebrand as Niagen Bioscience and change ticker By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 13, 2025

Q1 Earnings Forecast for ChromaDex Issued By HC Wainwright - Defense World

Mar 13, 2025

Mar 13, 2025

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace

Mar 13, 2025

Mar 13, 2025

ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India

Mar 13, 2025

Mar 13, 2025

Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan

Mar 13, 2025

Mar 12, 2025

ChromaDex to Present at the 37th Annual Roth Conference - BioSpace

Mar 12, 2025

Mar 11, 2025

Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan

Mar 11, 2025

Mar 11, 2025

ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com

Mar 10, 2025